Quarterly Result5 May 2026, 02:33 pm
Emcure Pharma: Standalone & Consolidated Results for FY26
AI Summary
Emcure Pharmaceuticals Ltd. announced its audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The results were approved by the Board of Directors in a meeting held on May 5, 2026, following a review and recommendation by the Audit Committee. The financial results and audit reports from B S R & Co. LLP are enclosed.
Key Highlights
- Audited financial results (standalone and consolidated) approved for FY26.
- Board meeting held on May 5, 2026, to approve the results.
- Audit reports issued by B S R & Co. LLP enclosed.
- Meeting commenced at 12.42 p.m. (IST) and concluded at 2.00 p.m. (IST).
Price Impact
More from EMCURE